Rambus stock drops as sales, outlook fall short
Rambus Inc. (RMBS) shares dropped in the extended session Monday after the chip and sensor maker's forecast fell short of the Wall Street consensus. Rambus shares fell more than 8% after hours, following a 0.1% uptick in the regular session to close at $62.61. The company reported second-quarter net income of $168.9 million, or $1.51 a share -- largely because of a $155.3 million tax benefit. Before the tax benefit the company reported net income of $13.6 million, or about 12 cents a share, compared with net income of $35 million, or 31 cents a share, in the year-ago period. Revenue declined to $119.8 million from $121.1 million in the year-ago quarter. Analysts surveyed by FactSet had forecast 39 cents a share on revenue of $138 million. Rambus forecast third-quarter licensing billings to be between $59 million and $65 million, while the Street expected $65 million, on average. Rambus also forecast product revenue between $47 million and $53 million, while analysts estimated $61.8 million; and estimated contract and other revenue to be between $17 million and $23 million, while the Street forecast $22.2 million.
-Wallace Witkowski
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-31-23 1728ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits